What Is Acurx Pharmaceuticals, Inc. (ACXP) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Acurx Pharmaceuticals, Inc. at $1.75. With an estimated intrinsic value of $3.24 and 5 of 7 models pointing higher, the average implied return is +85.2%. The most optimistic model, First Chicago, places fair value at $6.31 (+260.7%), while ML-RIV — the most conservative — estimates $0.12 (-93.4%). This +354.2% gap reflects genuine analytical uncertainty about Acurx Pharmaceuticals, Inc.'s intrinsic worth.
What Do the Models Say About ACXP?
7 of 13 models are currently active for ACXP. Of these, 5 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates ACXP's intrinsic value at $1.92, implying +9.9% upside from the current price. See which stocks rank higher →
How Does ACXP Rank in Biotechnology?
Among 76 Biotechnology stocks, ACXP ranks #61 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to biotech businesses. For Acurx Pharmaceuticals, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.
Is ACXP a Value Trap?
CirclFi's Value Trap algorithm assigns ACXP a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Acurx Pharmaceuticals, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Acurx Pharmaceuticals, Inc. scores 4.2 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +354.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ACXP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ACXP's 7 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad